• Home
  • About
  • Leaders in Technologies & Treatments

Leaders in Technologies & Treatments

Opened a Family Health Center in Bristol with primary care and walk-in medical office, outpatient lab, radiology and wound care.

Continued construction of state-of-the-art $40 million, 70,000-square-foot cancer center on the Plainville/New Britain town line to enhance community access to comprehensive, multidisciplinary cancer-treatment services.

Emergency Department (ED) at Bradley Memorial Campus achieved Press Ganey patient satisfaction scores exceeding 95th percentile for their peer group and all EDs during FY 2014. High levels of performance also included Centers for Medicaid and Medicare Services (CMS) benchmarks of time from arrival to provider, treatment time, and time-to-admission decision.

Earned Joint Commission’s Gold Seal of Approval for knee- and hip-replacement program.

Cancer program earned three-year accreditation with commendations from Commission on Cancer of American College of Surgeons. Received gold-level accreditation with commendations in seven categories.

Became first Connecticut facility to adopt Volpara Density™ breast-imaging software for women with dense breast tissue.

HOCC’s primary percutaneous coronary intervention achieved a mean door-to-balloon time of 60 minutes.

Established weekly group sessions for HOCC’s gestational diabetes patients.

Lowered congestive heart failure read mission rate to 15 percent.

HOCC listed as an award-winning hospital on American Hospital Association (AHA) healthcare quality map in an AHA advertisement in US News & World Report, Best Hospitals edition and at Scientific Sessions in November 2014 for STEMI care (Mission: Lifeline Bronze Recipients).

HOCC is one of a few health care facilities in the state to offer a Centering-Pregnancy™ program, focusing on second- and third-trimester wellness visits and education in a group setting. The program is offered primarily to underinsured and uninsured pregnant patients.

Hosted Keep the Power on Utility Clinic to help local community members with utility bills.

HOCC Psychiatry Department and Hartford HealthCare Behavioral Health Network sponsored “Raising Awareness, Breaking Down Barriers” event as part of the National Dialogue on Mental Health Series to raise public awareness of mental illness.

Participating in two major, national research studies: the Cardiovascular Inflammation Reduction Trial, a long-term study examining whether or not methotrexate can improve outcomes inpatients who have had heart attacks or have coronary artery disease; and a pilot study, Cool Arrest, to test a device used to provide therapeutic hypothermia treatment for patients who have had cardiac arrest.

Women’s Heart Wellness Center received $15,000 from Running with Scissors organization.

HOCC named beneficiary of a $1.3 million charitable fund from estate of Myrna (Morse) Pauloz through the Community Foundation of Greater New Britain.

Donations supporting the new cancer center include:

  • $50,000 from Tilcon Connecticut on behalf of its employees.
  • $1 million from American Savings Foundation.
  • $500,000 donation from Stanley Black & Decker.
  • $1.5 million donation from Maximilian E. &Marion O. Hoffman Foundation for new state of-the-art breast center.

HOCC named one of less than 2 percent of U.S.-registered hospitals to meet the Centers for Medicaid and Medicare Services Stage 2 criteria for meaningful use of electronic health records.

HOCC among only 375 hospitals in the nation listed as “Most Wired."

Recognized for excellence in lactation care by International Board of Lactation Consultant Examiners® and International Lactation Consultant Association.

Received Get with the Guidelines – Stroke Gold-Plus Quality Achievement Award and Heart Failure Bronze Quality Achievement Award from American Heart Association (AHA)/American Stroke Association and American Heart Association/American College of Cardiology Foundation.

Received American Heart Association’s Mission: Lifeline® Bronze Plus Receiving Quality Achievement Award for implementing quality-improvement measures to treat ST-elevation myocardial infarction (STEMI) heart attacks.

Corporate Communications